Gene: HSD17B12
Official Full Name: hydroxysteroid 17-beta dehydrogenase 12provided by HGNC
Gene Summary: This gene encodes a very important 17beta-hydroxysteroid dehydrogenase (17beta-HSD) that converts estrone into estradiol in ovarian tissue. This enzyme is also involved in fatty acid elongation. [provided by RefSeq, Oct 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22947 | HSD17B12 Knockout cell line (HeLa) | Human | HSD17B12 | 1:3~1:6 | Negative | Online Inquiry |
KO22948 | HSD17B12 Knockout cell line (HCT 116) | Human | HSD17B12 | 1:2~1:4 | Negative | Online Inquiry |
KO22949 | HSD17B12 Knockout cell line (HEK293) | Human | HSD17B12 | 1:3~1:6 | Negative | Online Inquiry |
KO22950 | HSD17B12 Knockout cell line (A549) | Human | HSD17B12 | 1:3~1:4 | Negative | Online Inquiry |
HSD17B12 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to study the functional role of the HSD17B12 gene, involved in steroid biosynthesis and lipid metabolism. This product contains knockout versions of these cell lines, allowing researchers to examine the phenotypic consequences of HSD17B12 ablation. By disrupting this gene, users can explore its regulatory mechanisms in steroid hormone production and fatty acid metabolism, providing insights into various metabolic disorders and hormone-related diseases.
The key function of these knockout cell lines lies in their ability to mimic loss-of-function mutations in vitro, facilitating the investigation of HSD17B12’s pathway in metabolic processes. Mechanistically, HSD17B12 encodes an enzyme crucial for the conversion of 17-beta-hydroxysteroids, influencing both the biosynthesis of steroid hormones and fatty acids. By studying these knockout models, researchers can elucidate how disruptions in these pathways lead to conditions such as obesity, cardiovascular disease, and reproductive disorders.
In scientific research and clinical settings, HSD17B12 Gene Knockout Cell Lines offer significant advantages. They provide reproducible experimental conditions that enable high-throughput screening of potential therapeutic compounds targeting lipid metabolism and sterile inflammation. Furthermore, these models serve as a powerful tool for understanding genetic predispositions to metabolic syndrome and evaluating drug efficacy in correcting metabolic dysfunctions.
Unlike traditional models, our HSD17B12 knockout cell lines boast superior specificity and reliability, allowing for robust data generation while minimizing variability associated with primary cell cultures. The precise gene editing techniques utilized ensure that researchers work with cell lines exhibiting complete gene ablation, which is crucial for obtaining accurate, actionable insights.
Our commitment to advancing biomedical research is exemplified by our expertise in producing high-quality cell lines tailored for specialized applications. By choosing HSD17B12 Gene Knockout Cell Lines, researchers and clinicians gain a vital resource to accelerate their studies in metabolism and related therapeutic areas, culminating in enhanced understanding and innovative treatment approaches.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.